» Articles » PMID: 34693750

A Quick and Efficient Method for the Generation of Immunomodulatory Mesenchymal Stromal Cell from Human Induced Pluripotent Stem Cell

Overview
Date 2021 Oct 25
PMID 34693750
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stromal cells (MSCs) have been widely investigated for their regenerative capacity, anti-inflammatory properties and beneficial immunomodulatory effects across multiple clinical indications. Nevertheless, their widespread clinical utilization is limited by the variability in MSC quality, impacted by donor age, metabolism, and disease. Human induced pluripotent stem cells (hiPSCs) generated from readily accessible donor tissues, are a promising source of stable and rejuvenated MSC but differentiation methods generally require prolonged culture and result in low frequencies of stable MSCs. To overcome this limitation, we have optimized a quick and efficient method for hiPSC differentiation into footprint-free MSCs (human induced MSCs [hiMSCs]) in this study. This method capitalizes on the synergistic action of growth factors Wnt3a and Activin A with bone morphogenetic protein-4 (BMP4), leading to an enrichment of MSC after only 4 days of treatment. These hiMSCs demonstrate a significant upregulation of mesenchymal stromal markers (CD105, CD90, CD73, and cadherin 11) compared with bone marrow-derived MSCs (bmMSCs), with reduced expression of the pluripotency genes (octamer-binding transcription factor [], cellular myelocytomatosis oncogene []]) compared with hiPSC. Moreover, they show improved proliferation capacity in culture without inducing any teratoma formation . Osteogenesis, chondrogenesis, and adipogenesis assays confirmed the ability of hiMSCs to differentiate into the three different lineages. Secretome analyses showed cytokine profiles compared with bmMSCs. Encapsulated hiMSCs in alginate beads cocultured with osteoarthritic (OA) cartilage explants showed robust immunomodulation, with stimulation of cell growth and proteoglycan production in OA cartilage. Our quick and efficient protocol for derivation of hiMSC from hiPSC, and their encapsulation in microbeads, therefore, presents a reliable and reproducible method to boost the clinical applications of MSCs.

Citing Articles

Regenerative medicine: Hydrogels and mesoporous silica nanoparticles.

Pablos J, Lozano D, Manzano M, Vallet-Regi M Mater Today Bio. 2024; 29:101342.

PMID: 39649249 PMC: 11625165. DOI: 10.1016/j.mtbio.2024.101342.


INDUCED PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STEM CELLS-DERIVED EXTRACELLULAR VESICLES ATTENUATE LPS-INDUCED LUNG INJURY AND ENDOTOXEMIA IN MICE.

Meng Q, Winston T, Ma J, Song Y, Wang C, Yang J Shock. 2024; 62(2):294-303.

PMID: 38813932 PMC: 11466509. DOI: 10.1097/SHK.0000000000002381.


Tendon stem/progenitor cells are promising reparative cell sources for multiple musculoskeletal injuries of concomitant articular cartilage lesions associated with ligament injuries.

Yin H, Mao K, Huang Y, Guo A, Shi L J Orthop Surg Res. 2023; 18(1):869.

PMID: 37968672 PMC: 10647040. DOI: 10.1186/s13018-023-04313-3.


Human retinal secretome: A cross-link between mesenchymal and retinal cells.

Donato L, Scimone C, Alibrandi S, Scalinci S, Morda D, Rinaldi C World J Stem Cells. 2023; 15(7):665-686.

PMID: 37545752 PMC: 10401416. DOI: 10.4252/wjsc.v15.i7.665.


Engineering considerations of iPSC-based personalized medicine.

Park S, Gwon Y, Khan S, Jang K, Kim J Biomater Res. 2023; 27(1):67.

PMID: 37420273 PMC: 10326963. DOI: 10.1186/s40824-023-00382-x.


References
1.
Diederichs S, Tuan R . Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. Stem Cells Dev. 2014; 23(14):1594-610. PMC: 4086513. DOI: 10.1089/scd.2013.0477. View

2.
Brennan M, Layrolle P, Mooney D . Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration. Adv Funct Mater. 2020; 30(37). PMC: 7494127. DOI: 10.1002/adfm.201909125. View

3.
Tanaka M, Jokubaitis V, Wood C, Wang Y, Brouard N, Pera M . BMP inhibition stimulates WNT-dependent generation of chondrogenic mesoderm from embryonic stem cells. Stem Cell Res. 2009; 3(2-3):126-41. DOI: 10.1016/j.scr.2009.07.001. View

4.
Hirschi K, Li S, Roy K . Induced pluripotent stem cells for regenerative medicine. Annu Rev Biomed Eng. 2014; 16:277-94. PMC: 4287204. DOI: 10.1146/annurev-bioeng-071813-105108. View

5.
Ruiz M, Toupet K, Maumus M, Rozier P, Jorgensen C, Noel D . TGFBI secreted by mesenchymal stromal cells ameliorates osteoarthritis and is detected in extracellular vesicles. Biomaterials. 2019; 226:119544. DOI: 10.1016/j.biomaterials.2019.119544. View